Cours Pathfinder Cell Therapy, Inc. Other OTC
Actions
PFND
US70319A1060
Recherche biotechnologique et médicale
CA 2013 | 0,05 0,05 | CA 2014 | - | Capitalisation | 534 k 478 k |
---|---|---|---|---|---|
Résultat net 2013 | -1 M -896 k | Résultat net 2014 | -1 M -896 k | VE / CA 2013 | 246 023 185 x |
Dette nette 2013 | 3,94 M 3,53 M | Dette nette 2014 | 4,96 M 4,44 M | VE / CA 2014 | - |
PER 2013 |
-5,48
x | PER 2014 |
-0,38
x | Employés | - |
Rendement 2013 * |
-
| Rendement 2014 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Rick Franklin
CEO | Chief Executive Officer | 78 | 02/09/11 |
John Benson
DFI | Director of Finance/CFO | 62 | 02/09/11 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Rick Franklin
CEO | Chief Executive Officer | 78 | 02/09/11 |
John Benson
DFI | Director of Finance/CFO | 62 | 02/09/11 |
Varia. 1 janv. | Capi. | |
---|---|---|
+51,85% | 59,28 Md | |
+41,42% | 40,94 Md | |
-5,25% | 40,17 Md | |
-5,16% | 28,69 Md | |
+12,79% | 26,63 Md | |
-20,18% | 18,89 Md | |
+30,88% | 12,46 Md | |
+0,61% | 12,42 Md | |
+25,06% | 12,26 Md |